A group representing White and Asian American applicants will try to persuade a federal appeals court in Manhattan to revive its challenge to a Pfizer Inc. fellowship program designed to build a diverse workforce.

Do No Harm, an advocacy membership group of health-care professionals, students, and policy makers, will participate in oral arguments Tuesday before a three-judge panel of the US Court of Appeals for the Second Circuit in its bid to shut down the pharmaceutical giant’s diversity program on the ground that it violates federal civil rights laws and the Affordable Care Act.

Up Next

Pfizer’s Diversity Fellowship Under Scrutiny in Job Bias Case